Aller au contenu principal

Aus der ZeitschriftLSR 1/2019 | p. 15–33Es folgt Seite №15

Financial Transparency in Industry-Physician Relationships

Part I: Analysis and Critical Assessment of the Swiss Pharma Cooperation Code

[…]